Search research articles
Contact Us
Filters
Showing results (131-140 of 156) with videos related to
Page
of 16
Sort By:
The Pharmacogenomics Journal
|
January 9, 2013
Role of immunoglobulin G fragment C receptor polymorphism-mediated antibody-dependant cellular cytotoxicity in colorectal cancer treated with cetuximab therapy
F V Negri, A Musolino, N Naldi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 4, 2003
Economic evaluation of antibiotic prophylaxis in small-cell lung cancer patients receiving chemotherapy: an EORTC double-blind placebo-controlled phase III study (08923)
V C G Tjan-Heijnen, S Caleo, P E Postmus, et al.
Journal of Cancer Policy
|
July 28, 2021
Transformation of Cancer Care during and after the COVID Pandemic, a point of no return. The Experience of Italy
R Tarricone, E Listorti, V Tozzi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 16, 2002
Phase III randomised trial comparing paclitaxel/carboplatin with paclitaxel/cisplatin in patients with advanced non-small-cell lung cancer: a cooperative multinational trial
R Rosell, U Gatzemeier, D C Betticher, et al.
Tumori
|
July 30, 1999
The role of vindesine and lonidamine in the treatment of elderly patients with advanced non-small cell lung cancer: a phase III randomized FONICAP trial. Italian Lung Cancer Task Force
F De Marinis, M Rinaldi, A Ardizzoni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 5, 2002
Reduction of chemotherapy-induced febrile leucopenia by prophylactic use of ciprofloxacin and roxithromycin in small-cell lung cancer patients: an EORTC double-blind placebo-controlled phase III study
V C Tjan-Heijnen, P E Postmus, A Ardizzoni, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 21, 1998
Role of recombinant interferon-gamma maintenance in responding patients with small cell lung cancer. A randomised phase III study of the EORTC Lung Cancer Cooperative Group
N van Zandwijk, H J Groen, P E Postmus, et al.
American Journal of Clinical Oncology
|
February 22, 2000
Ambamustine in the second-line treatment of patients with small-cell lung cancer: a phase II Fonicap study
A Ardizzoni, G Antonelli, S Ricci, et al.
British Journal of Cancer
|
April 14, 2011
Comparison of HER2 status in primary and paired metastatic sites of gastric carcinoma
C Bozzetti, F V Negri, C A Lagrasta, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 8, 2016
Pemetrexed plus carboplatin versus pemetrexed in pretreated patients with advanced non-squamous non-small-cell lung cancer: treating the right patients based on individualized treatment effect prediction
R C M van Kruijsdijk, F L J Visseren, L Boni, et al.
Page
of 16
Search research articles
Search
Showing results (131-140 of 156) with videos related to
Sort By:
Page
of 16
The Pharmacogenomics Journal
|
January 9, 2013
Role of immunoglobulin G fragment C receptor polymorphism-mediated antibody-dependant cellular cytotoxicity in colorectal cancer treated with cetuximab therapy
F V Negri, A Musolino, N Naldi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 4, 2003
Economic evaluation of antibiotic prophylaxis in small-cell lung cancer patients receiving chemotherapy: an EORTC double-blind placebo-controlled phase III study (08923)
V C G Tjan-Heijnen, S Caleo, P E Postmus, et al.
Journal of Cancer Policy
|
July 28, 2021
Transformation of Cancer Care during and after the COVID Pandemic, a point of no return. The Experience of Italy
R Tarricone, E Listorti, V Tozzi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 16, 2002
Phase III randomised trial comparing paclitaxel/carboplatin with paclitaxel/cisplatin in patients with advanced non-small-cell lung cancer: a cooperative multinational trial
R Rosell, U Gatzemeier, D C Betticher, et al.
Tumori
|
July 30, 1999
The role of vindesine and lonidamine in the treatment of elderly patients with advanced non-small cell lung cancer: a phase III randomized FONICAP trial. Italian Lung Cancer Task Force
F De Marinis, M Rinaldi, A Ardizzoni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 5, 2002
Reduction of chemotherapy-induced febrile leucopenia by prophylactic use of ciprofloxacin and roxithromycin in small-cell lung cancer patients: an EORTC double-blind placebo-controlled phase III study
V C Tjan-Heijnen, P E Postmus, A Ardizzoni, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 21, 1998
Role of recombinant interferon-gamma maintenance in responding patients with small cell lung cancer. A randomised phase III study of the EORTC Lung Cancer Cooperative Group
N van Zandwijk, H J Groen, P E Postmus, et al.
American Journal of Clinical Oncology
|
February 22, 2000
Ambamustine in the second-line treatment of patients with small-cell lung cancer: a phase II Fonicap study
A Ardizzoni, G Antonelli, S Ricci, et al.
British Journal of Cancer
|
April 14, 2011
Comparison of HER2 status in primary and paired metastatic sites of gastric carcinoma
C Bozzetti, F V Negri, C A Lagrasta, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 8, 2016
Pemetrexed plus carboplatin versus pemetrexed in pretreated patients with advanced non-squamous non-small-cell lung cancer: treating the right patients based on individualized treatment effect prediction
R C M van Kruijsdijk, F L J Visseren, L Boni, et al.
Page
of 16